Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Total Current Liabilities (2019 - 2026)

Viatris (VTRS) posted Total Current Liabilities of $6.3 billion for Q2 2026, down 6.82% on a QoQ basis from $6.8 billion in Q1 2026, and down 11.04% year-over-year from $7.1 billion in Q2 2025.

Analysis

Viatris (VTRS) Total Current Liabilities (2019 - 2026) Analysis & Trends

Viatris has reported Total Current Liabilities for 8 years, with the latest figure at $6.3 billion in Q2 2026.

  • On a quarterly basis, Total Current Liabilities fell 11.04% year-over-year to $6.3 billion in Q2 2026; TTM through Jun 2026 was $6.3 billion, a 11.04% decrease from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 22.75% from the prior year.
  • Total Current Liabilities was $6.3 billion for Q2 2026 at Viatris, down from $6.8 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $9.6 billion in Q1 2022, with the low at $5.7 billion in Q1 2025.
  • Average Total Current Liabilities over 5 years is $7.1 billion, with a median of $7.0 billion recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Total Current Liabilities slumped 36.66% in 2023, then gained 27.04% in 2024.
  • Over 5 years, Total Current Liabilities stood at $6.7 billion in 2022, then gained by 15.29% to $7.8 billion in 2023, then decreased by 25.69% to $5.8 billion in 2024, then increased by 22.75% to $7.1 billion in 2025, then declined by 10.55% to $6.3 billion in 2026.
  • The last three Total Current Liabilities figures came in at $6.3 billion (Q2 2026), $6.8 billion (Q1 2026), and $7.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 15.65 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 6.35 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 1.66 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 883.19 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 4.54 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 331.18 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 283.66 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 263.21 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 12.39 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 19.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.35 Bn
Mar 31, 2026 6.81 Bn
Dec 31, 2025 7.09 Bn
Sep 30, 2025 7.36 Bn
Jun 30, 2025 7.13 Bn
Mar 31, 2025 5.72 Bn
Dec 31, 2024 5.78 Bn
Sep 30, 2024 7.51 Bn
Jun 30, 2024 7.71 Bn
Mar 31, 2024 7.76 Bn
Dec 31, 2023 7.78 Bn
Sep 30, 2023 6.83 Bn
Jun 30, 2023 6.52 Bn
Mar 31, 2023 6.11 Bn
Dec 31, 2022 6.75 Bn
Sep 30, 2022 6.52 Bn
Jun 30, 2022 7.68 Bn
Mar 31, 2022 9.64 Bn
Dec 31, 2021 9.88 Bn
Sep 30, 2021 10.10 Bn